{rfName}

Indexed in

License and use

Altmetrics

Grant support

O.G. received a personal research grant from the 'Pla estrategic de recerca i innovacioen salut (PERIS) 2019-2021' (Departament de Salut, Generalitat de Catalunya). This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Analysis of institutional authors

Iftimie Iftimie, Simona MihaelaAuthor

Share

Publications
>
Article

Decreased Mortality among Patients with Catheter-Related Bloodstream Infections at Catalan Hospitals (2010-2019)

Publicated to:Journal Of Hospital Infection. 126 70-77 - 2022-08-01 126(), DOI: 10.1016/j.jhin.2022.05.009

Authors: Badia-Cebada, L; Penafiel, J; Lopez-Contreras, J; Pomar, V; Martinez, J A; Santana, G; Cuquet, J; Montero, M M; Hidalgo-Lopez, C; Andres, M; Gimenez, M; Quesada, M D; Vaque, M; Iftimie, S; Gudiol, C; Perez, R; Coloma, A; Marron, A; Barrufet, P; Marimon, M; Lerida, A; Claros, M; Ramirez-Hidalgo, M F; Garcia Pardo, G; Martinez, M J; Chamarro, E L; Jimenez-Martinez, E; Hornero, A; Limon, E; Lopez, M; Calbo, E; Pujol, M; Gasch, O

Affiliations

CEXS Univ Pompeu Fabra, Inst Hosp Mar Invest Med IMIM, Infect Pathol & Antimicrobials Res Grp IPAR 10, Barcelona, Spain - Author
Dept Bellvitge Univ Hosp, Inst Catalci Oncol, Inst Invest Biomed Bellvitge IDIBELL Hosp Llobreg, Infect Dis Dept, Barcelona, Spain - Author
Hosp Arnau Vilanova, Terr Unit Nosocomial Infect, Lleida, Spain - Author
Hosp Badalona Germans Trias & Pujol, Microbiol Dept, Metropolitana Nord Clin Lab, Badalona, Spain - Author
Hosp Barcelona, Infect Control Nurse, Barcelona, Spain - Author
Hosp Clin Barcelona, Infect Dis Dept, Barcelona, Spain - Author
Hosp Clin Barcelona, Serv Prevent Med, Infect Control Nurse, Barcelona, Spain - Author
Hosp Consorci Terrassa, Dept Internal Med, Infect Dis Unit, Terrassa, Spain - Author
Hosp Gen Granollers, Dept Internal Med, Infect Dis Unit, Catalonia, Spain - Author
Hosp Mar, Infect Dis Serv, Barcelona, Spain - Author
Hosp Mataro, Dept Internal Med, Infect Dis Unit, Mataro, Spain - Author
Hosp St Joan Despi Moises Broggi, Infect Dis Unit, Dept Internal Med, St Joan Despi, Spain - Author
Hosp St Joan Deu Manresa, Infect Dis Unit, Dept Internal Med, Althaia, Spain - Author
Hosp St Rafael, Infect Dis Unit, Dept Internal Med, Barcelona, Spain - Author
Hosp Tortosa Verge de la Cinta, Infect Dis Unit, Tortosa, Spain - Author
Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Infect Control Nurse, Lhospitalet De Llobregat, Spain - Author
Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Infect Dis Dept, Lhospitalet De Llobregat, Spain - Author
Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Unit Stat, Lhospitalet De Llobregat, Spain - Author
Hosp Univ Gen Catalunya, Infect Dis Unit, Sant Cugat Del Valles, Spain - Author
Hosp Univ Igualada, Dept Internal Med, Infect Dis Unit, Igualada, Spain - Author
Hosp Univ St Joan de Reus, Infect Dis Unit, Dept Internal Med, Tarragona, Spain - Author
Hosp Univ Vic, Dept Internal Med, Infect Dis Unit, Vic, Spain - Author
Hosp Viladecans, Dept Internal Med, Infect Dis Unit, Viladecans, Spain - Author
Infection Control Nurse, Hospital de Barcelona, Spain. - Author
Infection Control Nurse, Service of Preventive Medicine, Hospital Clínic de Barcelona. - Author
Infectious Diseases Department, Bellvitge University Hospital, Institut Català d'Oncologia. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) l'Hospitalet de Llobregat, Barcelona, Spain. - Author
Infectious diseases Department, Hospital Universitari de Bellvitge. Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Spain - Author
Infectious Diseases Department. Hospital Universitari Parc Taulí. Institut d'Investigació i Innovació Parc Taulí. Universitat Autònoma de Barcelona, Sabadell, Spain. Electronic address: ogasch@tauli.cat. - Author
Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials 10 Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), CEXS-Universitat Pompeu Fabra, Barcelona, Spain Infectious Diseases Unit, Department of Internal Medicine. Consorci Sanitari de Terrassa, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine, Hospital General de Granollers, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Althaia. Hospital de Sant Joan de Déu de Manresa, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital Consorci de Terrassa, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital de Mataró, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital de Sant Joan Despí Moisès Broggi, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital de Viladecans, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital Sant Rafael, Barcelona, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital Universitari d'Igualada, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital Universitari de Vic, Spain. - Author
Infectious Diseases Unit, Department of Internal Medicine. Hospital Universitari Sant Joan de Reus, Spain. - Author
Infectious Diseases Unit, Hospital Universitari Mútua Terrassa, Terrassa, Spain - Author
Infectious Diseases Unit-Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica de Sant Pau (IIB Sant Pau), University Autónoma de Barcelona, Barcelona, Spain. - Author
Infectious Diseases Unit. Hospital de Tortosa Verge de la Cinta, Tortosa, Spain. - Author
Infectious Diseases Unit. Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Spain. - Author
Inst Recerca Biomed Lleida, IRBLLEIDA, TRIDLE Grp, Lleida, Spain - Author
Internal Medicine Department. Hospital Universitari Parc Taulí. Institut d'Investigació i Innovació Parc Taulí. Universitat Autònoma de Barcelona, Sabadell, Spain. - Author
Microbiology Department, Metropolitana Nord Clinical Laboratory, Hospital Germans Trias i Pujol, Badalona, Spain. - Author
NULL - Author
Territorial Unit of Nosocomial Infection, Hospital Universitari Arnau de Vilanova, Lleida, Spain - Author
TRIDLE group, Institut de Recerca Biomèdica de Lleida, IRBLLEIDA, Lleida, Spain. - Author
Univ Autonoma Barcelona, Infect Dis Dept, Inst Invest & Innovacio Parc Tauli, Hosp Univ Parc Tauli, Sabadell, Spain - Author
Univ Autonoma Barcelona, Infect Dis Unit, Internal Med Dept, Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain - Author
Univ Autonoma Barcelona, Internal Med Dept, Hosp Univ Parc Tauli, Inst Invest & Innovacid Parc Tauli, Sabadell, Spain - Author
Univ Barcelona, Fac Med & Hlth Sci, Sch Nursing, Dept Publ Hlth Mental Hlth & Mother Infant Nursin, Barcelona, Spain - Author
Univ Int Catalunya, Hosp Univ Mutua Terrassa, Infect Dis Unit, Terrassa, Spain - Author
Univ Rovira & Virgili, Infect Control Grp, Dept Prevent Med,Inst Invest Sanitciries Pere Vir, Hosp Univ Tarragona Joan XXIII,Infect & Immun Res, Tarragona, Spain - Author
Universitat Autònoma de Barcelona. - Author
VINCAT Program Surveillance Nosocomial Infect Cat, Barcelona, Spain - Author
See more

Abstract

The incidence of catheter-related bloodstream infections (CRBSI) has fallen over the last decade, especially in intensive care units (ICUs).To assess the existence of concomitant trends in outcomes and to analyse the current risk factors for mortality.A multicentre retrospective cohort study was conducted at 24 Catalan hospitals participating in the Surveillance of healthcare associated infections in Catalonia (VINCat). All hospital-acquired CRBSI episodes diagnosed from January 2010 to December 2019 were included. A common protocol including epidemiological, clinical and microbiological data was prospectively completed. Mortality at 30 days after bacteraemia onset was analysed using the Cox regression model.Over the study period, 4,795 episodes of CRBSI were diagnosed. Among them, 75% were acquired in conventional wards and central venous catheters were the most frequently involved (61%). The 30-day mortality rate was 13.8%, presenting a significant downward trend over the study period: from 17.9% in 2010 to 10.6% in 2019 (HR 0.95 [0.92-0.98]). The multivariate analysis identified age (HR 1.03 [1.02-1.04]), femoral catheter (HR 1.78 [1.33-2.38]), medical ward acquisition (HR 2.07 [1.62-2.65] and ICU acquisition (HR 3.45 [2.7-4.41]), S. aureus (HR 1.59 [1.27-1.99]) and Candida sp. (HR 2.19 [1.64-2.94]) as risk factors for mortality while the mortality rate associated with episodes originating in peripheral catheters was significantly lower (HR 0.69 [0.54-0.88]).Mortality associated with CRBSI has fallen in recent years but remains high. Intervention programs should focus especially on ICUs and medical wards, where incidence and mortality rates are highest.Copyright © 2022 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Keywords

carecatheter-related bloodstream infectioncostshealthcare-associated infectionicuimpactintervention programmemicrobiologymultimodal interventionpreventionsurveillanceBacteremiaCatheter-related bloodstream infectionCatheter-related bloodstream infectionsCatheter-related infectionsCentral venous cathetersHealthcare-associated infectionHospitalsHumansIncidenceIntervention programIntervention programmeMortalityRetrospective studiesRisk-factorsStaphylococcus aureus

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Journal Of Hospital Infection due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 27/207, thus managing to position itself as a Q1 (Primer Cuartil), in the category Public, Environmental & Occupational Health.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 3.12, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jun 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-06-15, the following number of citations:

  • WoS: 4
  • Scopus: 4
  • Europe PMC: 1
  • OpenCitations: 5

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-15:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 49.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 49 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 3.35.
  • The number of mentions on the social network X (formerly Twitter): 5 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is: